Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)
Hong Kong
· Delayed Price · Currency is HKD 6.22
+0.04 (0.65%)
Apr 29, 2026, 4:08 PM HKT
HKG:0719 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 261.7 | 289.89 | 470.02 | 496.51 | 411.06 | 348.55 | Upgrade
|
| Depreciation & Amortization | 587.52 | 587.52 | 540.95 | 516.94 | 489.4 | 438.58 | Upgrade
|
| Other Amortization | 4.35 | 4.35 | 4.73 | 3.32 | 2.75 | 2.48 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.99 | -1.99 | -1.42 | -8.73 | -5.54 | -2.07 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.11 | 1.11 | 5.12 | -33.26 | -39.29 | -84.79 | Upgrade
|
| Loss (Gain) From Sale of Investments | -7.76 | -7.76 | -9.84 | -9.58 | -8.36 | -8.02 | Upgrade
|
| Provision & Write-off of Bad Debts | 6.2 | 6.2 | 8.49 | 10.73 | 5.24 | 2.32 | Upgrade
|
| Other Operating Activities | 1.31 | 98.09 | 93.93 | 121.24 | 122.37 | 97.65 | Upgrade
|
| Change in Accounts Receivable | -547.75 | -547.75 | -629.94 | -423.54 | -717.33 | -751.07 | Upgrade
|
| Change in Inventory | -92.83 | -92.83 | -11.43 | -120.86 | -200.14 | 76.18 | Upgrade
|
| Change in Accounts Payable | 184.72 | 184.72 | -153.63 | -332.39 | 632.33 | 121.63 | Upgrade
|
| Change in Other Net Operating Assets | 12.52 | 12.52 | 35.88 | 53.07 | 45.8 | 3.96 | Upgrade
|
| Operating Cash Flow | 408.75 | 533.73 | 367.61 | 265.28 | 758.24 | 259.12 | Upgrade
|
| Operating Cash Flow Growth | 20.94% | 45.19% | 38.57% | -65.01% | 192.63% | -38.33% | Upgrade
|
| Capital Expenditures | -93.94 | -115.6 | -212.42 | -325.13 | -244.76 | -249.23 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.44 | 0.77 | 0.65 | 11.86 | 7.94 | 2.43 | Upgrade
|
| Investment in Securities | 1.53 | 1.53 | -8.63 | - | - | - | Upgrade
|
| Other Investing Activities | 11.41 | 9.8 | 8.18 | 8.17 | 7.92 | 9.11 | Upgrade
|
| Investing Cash Flow | -79.55 | -103.5 | -212.21 | -305.11 | -228.9 | -237.69 | Upgrade
|
| Long-Term Debt Issued | - | 979.8 | 860.31 | 862.43 | 833.79 | 551.41 | Upgrade
|
| Long-Term Debt Repaid | - | -1,114 | -554.05 | -888.15 | -1,106 | -603.48 | Upgrade
|
| Net Debt Issued (Repaid) | -223.99 | -133.72 | 306.26 | -25.72 | -272.57 | -52.07 | Upgrade
|
| Issuance of Common Stock | 45.94 | 53.17 | 63.26 | 6.02 | 274.69 | 32.97 | Upgrade
|
| Common Dividends Paid | -215.91 | -209.78 | -225.85 | -175.9 | -163.01 | -148.43 | Upgrade
|
| Other Financing Activities | 30.84 | -0.8 | 41.11 | -0.5 | 30.24 | 27.8 | Upgrade
|
| Financing Cash Flow | -363.12 | -291.13 | 184.78 | -196.11 | -130.66 | -139.73 | Upgrade
|
| Foreign Exchange Rate Adjustments | 6.07 | 7.24 | 15.01 | 6.86 | 15.69 | -7.87 | Upgrade
|
| Net Cash Flow | -27.85 | 146.33 | 355.19 | -229.08 | 414.37 | -126.17 | Upgrade
|
| Free Cash Flow | 314.81 | 418.13 | 155.19 | -59.85 | 513.48 | 9.89 | Upgrade
|
| Free Cash Flow Growth | 144.08% | 169.43% | - | - | 5092.02% | -92.94% | Upgrade
|
| Free Cash Flow Margin | 3.60% | 4.78% | 1.83% | -0.74% | 6.84% | 0.15% | Upgrade
|
| Free Cash Flow Per Share | 0.46 | 0.60 | 0.23 | -0.09 | 0.77 | 0.02 | Upgrade
|
| Cash Income Tax Paid | 172.73 | 142.5 | 96.2 | 239.79 | 66.25 | 44.5 | Upgrade
|
| Levered Free Cash Flow | 497.99 | 654.46 | 551.12 | 50.07 | 779.34 | 222.79 | Upgrade
|
| Unlevered Free Cash Flow | 524.51 | 680.98 | 575.96 | 75.79 | 810.41 | 255.98 | Upgrade
|
| Change in Working Capital | -443.67 | -443.67 | -744.37 | -831.87 | -219.39 | -535.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.